The DOI matches its Crossref record; its reference list is not available.
Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology
Abstract
For the detection of the precise and unambiguous binding of fragments to a specific binding site on the target protein, we have developed a novel reporter displacement binding assay technology. The application of this technology for the fragment screening as well as the fragment evolution process with a specific modelling based design strategy is demonstrated for inhibitors of the protein kinase p38alpha. In a fragment screening approach seed fragments were identified which were then used to build compounds from the deep-pocket towards the hinge binding area of the protein kinase p38alpha based on a modelling approach. BIRB796 was used as a blueprint for the alignment of the fragments. The fragment evolution of these deep-pocket binding fragments towards the fully optimized inhibitor BIRB796 included the modulation of the residence time as well as the affinity. The goal of our study was to evaluate the robustness and efficiency of our novel fragment screening technology at high fragment concentrations, compare the screening data with biochemical activity data and to demonstrate the evolution of the hit fragments with fast kinetics, into slow kinetic inhibitors in an in silico approach.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but their selectivity profiles extended well beyond these isoforms as reported previously (12, 13, 26, 29, 30, 38).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [29]
In the citing paper
“This is in agreement with previous studies investigating the role of HDACiongeneexpression changes in HL60 cells (2, 29, 30, 35, 43).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [29]
Citations
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 18 · Cited by 20
Research works printed but not linked: 17
- Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) J Med Chem 51:3661–3680. doi: 10.1021/jm8000373 · DOI
- Hann MM, Leach AR, Harper G (2001) J Chem Inf Comput Sci 41:856–864. doi: 10.1021/ci000403i · DOI
- Hann MM, Oprea TI (2004) Curr Opin Chem Biol 8:255–263. doi: 10.1016/j.cbpa.2004.04.003 · DOI
- Sutherland JJ, Higgs RE, Watson I, Vieth M (2008) J Med Chem 51:2689–2700. doi: 10.1021/jm701399f · DOI
- Babaoglu K, Shoichet B (2006) Nat Chem Biol 2:720–723. doi: 10.1038/nchembio831 · DOI
- Swinney DC (2004) Nat Rev Drug Discov 3:801–808. doi: 10.1038/nrd1500 · DOI
- Swinney DC (2006) Curr Top Med Chem 6:461–478. doi: 10.2174/156802606776743093 · DOI
- Wood ER, Truesdale AT, McDonald OB (2004) Cancer Res 64:6652–6659. doi: 10.1158/0008-5472.CAN-04-1168 · DOI
- Backes AC, Zech B, Felber B, Klebl B, Müller G (2008) Expert Opin Drug Discov 3:1409–1425. doi: 10.1517/17460440802579975 · DOI
- Backes AC, Zech B, Felber B, Klebl B, Müller G (2008) Expert Opin Drug Discov 3:1427–1449. doi: 10.1517/17460440802580106 · DOI
- Pargellis C, Tong L, Churchill L, Cirillo PF, Gilmore T, Graham AG (2002) Nat Struct Biol 9:268–272. doi: 10.1038/nsb770 · DOI
- Regan J, Pargellis CA, Cirillo PF, Gilmore T, Hickey ER, Peet GW (2003) Bioorg Med Chem Lett 13:3101–3104. doi: 10.1016/S0960-894X(03)00656-5 · DOI
- Frembgen-Kesner T, Elcock AH (2006) J Mol Biol 359:202–214. doi: 10.1016/j.jmb.2006.03.021 · DOI
- Gill AL, Frederickson M, Cleasby A, Woodhead SJ, Carr MG, Woodhead AJ, Walker MT, Congreve MS, Devine LA, Tisi D, O’Reilly M, Seavers LC, Davis DJ, Curry J, Anthony R, Padova A, Murray CW, Carr RA, Jhoti H (2005) J Med Chem 48:414–426. doi: 10.1021/jm049575n · DOI
- Dauber-Osguthorpe P, Roberts VA, Osguthorpe DJ, Wolff J, Genest M, Hagler MT (1988) Protein Struct Funct Genet 4:31. doi: 10.1002/prot.340040106 · DOI
- Cheng Y-C, Prusoff WH (1973) Biochem Pharmacol 22:3099–3108. doi: 10.1016/0006-2952(73)90196-2 · DOI · Paper page
- Zaman GJ, van der Lee MM, Kok JJ, Nelissen RL, Loomans EE (2006) Assay Drug Dev Technol 4(4):411–420 · DOI
Metadata
- Authors
- Neumann, L., Ritscher, A., Müller, G., & Hafenbradl, D.
- Corresponding author
- Hafenbradl, Doris
- Venue
- Journal of Computer-Aided Molecular Design
- Published
- 2009-06-17
- Volume
- 23
- Issue
- 8
- Pages
- 501-511
- ISSN
- 0920-654X (ISSN-L)
- 1573-4951
- OpenAlex
- W2058757325
- Cited by
- 20
- References
- 18
- Citations by year
- 2024: 2 · 2020: 1 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 2
- FWCI
- 2.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Computer-Aided Molecular Design (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- fragment screening, kinase inhibitors, residence time, binding affinity
- MeSH terms
- Binding Sites, Enzyme Inhibitors, Humans, Kinetics, Ligands, Models, Molecular, Protein Binding, Protein Conformation, Structure-Activity Relationship, p38 Mitogen-Activated Protein Kinases, Small Molecule Libraries, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology. https://app.cochat.ai/papers/10.1007/s10822-009-9288-x
- The paper
- Neumann, L., Ritscher, A., Müller, G., & Hafenbradl, D. (2009). Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology. Journal of Computer-Aided Molecular Design. https://doi.org/10.1007/s10822-009-9288-x